FDA
Lamivudine; Nevirapine; Zidovudine
The FDA lists this product in 6 strengths and forms.
Composition
- Active ingredients
- LAMIVUDINE 150MG; NEVIRAPINE 200MG; ZIDOVUDINE 300MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LAMIVUDINE 30MG; NEVIRAPINE 50MG; ZIDOVUDINE 60MG · TabletNDA203076-001 · Tentative approval
- LAMIVUDINE 150MG; NEVIRAPINE 200MG; ZIDOVUDINE 300MG · TabletNDA022061-001 · Tentative approval
- LAMIVUDINE 150MG; NEVIRAPINE 200MG; ZIDOVUDINE 300MG · TabletNDA022464-001 · Tentative approval
- LAMIVUDINE 30MG; NEVIRAPINE 50MG; ZIDOVUDINE 60MG · Tablet, for suspensionNDA202685-001 · Tentative approval
- LAMIVUDINE 150MG; NEVIRAPINE 200MG; ZIDOVUDINE 300MG · TabletThis page
- LAMIVUDINE 150MG; NEVIRAPINE 200MG; ZIDOVUDINE 300MG · TabletNDA202589-001 · Tentative approval
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA202157.